Cargando…

T Cell Response to Infliximab in Exposed Patients: A Longitudinal Analysis

This study aimed to evaluate the proportion of infliximab (IFX)-exposed patients exhibiting cellular response to the drug in a longitudinal way and to establish whether it is predictive for anti-drug antibodies (ADA) development. Seventeen patients suffering from immuno-mediated disorders were enrol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pratesi, Sara, Nencini, Francesca, Grosso, Francesca, Dies, Laura, Bormioli, Susanna, Cammelli, Daniele, Maggi, Enrico, Matucci, Andrea, Vultaggio, Alessandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336713/ https://www.ncbi.nlm.nih.gov/pubmed/30687319 http://dx.doi.org/10.3389/fimmu.2018.03113

Ejemplares similares

Rapid clinical improvement of atopic dermatitis in an Omalizumab treated patient
por: Bormioli, Susanna, et al.
Publicado: (2019)

Drug-specific Treg cells are induced during desensitization procedure for rituximab and tocilizumab in patients with anaphylaxis
por: Vultaggio, Alessandra, et al.
Publicado: (2021)

Low-Dose Mepolizumab Effectiveness in Patients Suffering From Eosinophilic Granulomatosis With Polyangiitis
por: Vultaggio, Alessandra, et al.
Publicado: (2020)

Efficacy and Safety of Mepolizumab (Anti-Interleukin-5) Treatment in Gleich’s Syndrome
por: Matucci, Andrea, et al.
Publicado: (2018)

Mechanisms of Drug Desensitization: Not Only Mast Cells
por: Vultaggio, Alessandra, et al.
Publicado: (2020)

How the immune system responds to therapeutic biological agents
por: Vultaggio, Alessandra, et al.
Publicado: (2016)

Asthma and Chronic Rhinosinusitis: How Similar Are They in Pathogenesis and Treatment Responses?
por: Matucci, Andrea, et al.
Publicado: (2021)

How to Prevent and Mitigate Hypersensitivity Reactions to Biologicals Induced by Anti-Drug Antibodies?
por: Vultaggio, Alessandra, et al.
Publicado: (2021)

Circulating T cells to infliximab are detectable mainly in treated patients developing anti‐drug antibodies and hypersensitivity reactions
por: Vultaggio, A., et al.
Publicado: (2016)

Strategies Targeting Type 2 Inflammation: From Monoclonal Antibodies to JAK-Inhibitors
por: Matucci, Andrea, et al.
Publicado: (2021)

Mechanisms of Action of Ig Preparations: Immunomodulatory and Anti-Inflammatory Effects
por: Matucci, Andrea, et al.
Publicado: (2015)

Treatment with 8-OH-modified adenine (TLR7 ligand)-allergen conjugates decreases T helper type 2-oriented murine airway inflammation
por: Nencini, Francesca, et al.
Publicado: (2015)

Is IgE or eosinophils the key player in allergic asthma pathogenesis? Are we asking the right question?
por: Matucci, Andrea, et al.
Publicado: (2018)

High Serum β-Lactams Specific/Total IgE Ratio Is Associated with Immediate Reactions to β-Lactams Antibiotics
por: Vultaggio, Alessandra, et al.
Publicado: (2015)

Systematic Review of Safety and Efficacy of Rituximab in Treating Immune-Mediated Disorders
por: Kaegi, Celine, et al.
Publicado: (2019)

The anti-IgE monoclonal antibody omalizumab as adjuvant treatment in desensitization to carboplatin in patients with ovarian cancer
por: Vultaggio, Alessandra, et al.
Publicado: (2021)

Case Report: A child with NFKB1 haploinsufficiency explaining the linkage between immunodeficiency and short stature
por: Ricci, S., et al.
Publicado: (2023)

The use of intravenous versus subcutaneous monoclonal antibodies in the treatment of severe asthma: a review
por: Matucci, Andrea, et al.
Publicado: (2018)

Infliximab trough levels are associated with endoscopic healing but not with transmural healing at one year treatment with infliximab in pediatric patients with Crohn’s disease
por: Choi, So Yoon, et al.
Publicado: (2023)

HLAII peptide presentation of infliximab increases when complexed with TNF
por: Casasola-LaMacchia, Andrea, et al.
Publicado: (2022)

Serum Free Light Chains in Common Variable Immunodeficiency Disorders: Role in Differential Diagnosis and Association With Clinical Phenotype
por: Scarpa, Riccardo, et al.
Publicado: (2020)

Association of Systemic Steroid Treatment and Outcome in Patients Treated with Immune Checkpoint Inhibitors: A Real-World Analysis
por: Paderi, Agnese, et al.
Publicado: (2021)

The 1926 novel, “One, no one, one hundred thousand”, metaphorizes the potential danger when the immune system is exposed to a repetitive antigen stimulation
por: Ferrazzo, Francesca, et al.
Publicado: (2023)

Characterization of Two TNF-Related Subtypes Predicting Infliximab Therapy Responses in Crohn’s Disease
por: Ye, Chenglin, et al.
Publicado: (2022)

Immunogenicity of Infliximab Among Patients With Behçet Syndrome: A Controlled Study
por: Esatoglu, Sinem Nihal, et al.
Publicado: (2020)

Longitudinal Variations of M. tuberculosis-Induced IFN-γ Responses in HIV-Negative Pregnant Women Exposed to Tuberculosis
por: Ranaivomanana, Paulo, et al.
Publicado: (2021)

A Novel Model Based on Serum Biomarkers to Predict Primary Non-Response to Infliximab in Crohn’s Disease
por: Li, Li, et al.
Publicado: (2021)

Clinical Significance of Novel Neutrophil-Based Biomarkers in the Diagnosis and Prediction of Response to Infliximab Therapy in Crohn’s Disease
por: Zhou, Zhou, et al.
Publicado: (2022)

Characterization of CD4 T Cell Epitopes of Infliximab and Rituximab Identified from Healthy Donors
por: Hamze, Moustafa, et al.
Publicado: (2017)

Formyl Peptide Receptors and Annexin A1: Complementary Mechanisms to Infliximab in Murine Experimental Colitis and Crohn’s Disease
por: de Paula-Silva, Marina, et al.
Publicado: (2021)

Artificial Neural Network Analysis-Based Immune-Related Signatures of Primary Non-Response to Infliximab in Patients With Ulcerative Colitis
por: Chen, Xuanfu, et al.
Publicado: (2021)

The shed P2X7 receptor is an index of adverse clinical outcome in COVID-19 patients
por: Vultaggio-Poma, Valentina, et al.
Publicado: (2023)

Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 in a Preliminary Study
por: Vultaggio, Alessandra, et al.
Publicado: (2020)

Anti-NMDAR encephalitis in Crohn’s disease undergoing long-term infliximab treatment: A case report
por: Oh, Shin Ju, et al.
Publicado: (2022)

Current knowledge of TNF-α monoclonal antibody infliximab in treating Kawasaki disease: a comprehensive review
por: Chen, Jiaying, et al.
Publicado: (2023)

Drug Tolerant Anti-drug Antibody Assay for Infliximab Treatment in Clinical Practice Identifies Positive Cases Earlier
por: Kharlamova, Nastya, et al.
Publicado: (2020)

Derlin-1, as a Potential Early Predictive Biomarker for Nonresponse to Infliximab Treatment in Rheumatoid Arthritis, Is Related to Autophagy
por: Cai, Yongsong, et al.
Publicado: (2022)

Diversity of immune responses in children highly exposed to SARS-CoV-2
por: Úbeda, María, et al.
Publicado: (2023)

Serum Levels of Infliximab and Anti-Infliximab Antibodies in Brazilian Patients with Crohn's Disease
por: Gomes, Luis Eduardo Miani, et al.
Publicado: (2019)

Exosomes Recovered From the Plasma of COVID-19 Patients Expose SARS-CoV-2 Spike-Derived Fragments and Contribute to the Adaptive Immune Response
por: Pesce, Elisa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6ie5j8u6qc5uqdvoga5pu4da8j